Nuo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Nuo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • Nuo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 46.6M shares, a 10.1% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 46.6M +4.28M +10.1% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 45.5M +3.67M +8.77% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 44.2M +2.44M +5.84% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 44.2M +2.44M +5.84% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 42.3M +518K +1.24% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 41.8M +717K +1.75% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 41.8M +4.67M +12.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 41.8M +4.67M +12.6% Dec 31, 2022 10-K 2024-04-19
Q3 2022 41.8M +11.5M +38.1% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 41.1M +10.8M +35.8% Jun 30, 2022 10-Q/A 2022-08-10
Q1 2022 37.1M +6.87M +22.7% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 37.1M +6.87M +22.7% Dec 31, 2021 10-K 2023-04-17
Q3 2021 30.3M +6.01M +24.8% Sep 30, 2021 10-Q 2022-11-04
Q2 2021 30.3M +6.01M +24.8% Jun 30, 2021 10-K 2022-04-15
Q1 2021 30.3M +6.01M +24.8% Mar 31, 2021 10-K 2022-04-15
Q4 2020 30.3M +6.54M +27.6% Dec 31, 2020 10-Q 2022-11-04
Q3 2020 24.2M +525K +2.21% Sep 30, 2020 10-K 2022-04-15
Q2 2020 24.2M +525K +2.21% Jun 30, 2020 10-K 2022-04-15
Q1 2020 24.2M +525K +2.21% Mar 31, 2020 10-K 2022-04-15
Q4 2019 23.7M 0 0% Dec 31, 2019 10-K 2022-04-15
Q3 2019 23.7M 0 0% Sep 30, 2019 10-Q 2020-01-31
Q2 2019 23.7M 0 0% Jun 30, 2019 10-Q 2019-08-19
Q1 2019 23.7M +1M +4.4% Mar 31, 2019 10-Q 2019-05-20
Q4 2018 23.7M +1M +4.4% Dec 31, 2018 10-Q 2020-01-31
Q3 2018 23.7M +995K +4.38% Sep 30, 2018 10-Q 2018-11-16
Q2 2018 23.7M +13.8M +139% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 22.7M +12.8M +129% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 22.7M +12.8M +129% Dec 31, 2017 10-K 2019-04-16
Q3 2017 22.7M +12.8M +129% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 9.93M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 9.93M -116M -92.1% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 9.93M -116M -92.1% Dec 31, 2016 10-K 2018-04-16
Q3 2016 9.93M -116M -92.1% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 9.93M -116M -92.1% Jun 30, 2016 10-Q 2016-10-24
Q1 2016 126M 0 0% Mar 31, 2016 10-Q 2016-10-24
Q4 2015 126M 0 0% Dec 31, 2015 10-K 2017-03-29
Q3 2015 126M +1.27M +1.02% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 126M +3.98M +3.27% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 126M +4.35M +3.59% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 126M +18.5M +17.3% Dec 31, 2014 10-K 2016-10-24
Q3 2014 124M +19.2M +18.3% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 122M +16.9M +16.1% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 121M +17M +16.3% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 107M +13.4M +14.2% Dec 31, 2013 10-K 2015-03-31
Q3 2013 105M +13.7M +15% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 105M +14.1M +15.5% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 104M +33.4M +47.1% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 93.8M +38.3M +68.9% Dec 31, 2012 10-K 2014-03-31
Q3 2012 91.5M +38.7M +73.4% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 90.7M +38.7M +74.6% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 70.9M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 55.5M +11.4M +25.9% Dec 31, 2011 10-K 2013-03-18
Q3 2011 52.8M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 52M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 44.1M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.